IVERIC BIO INC's ticker is ISEE and the CUSIP is 46583P102. A total of 171 filers reported holding IVERIC BIO INC in Q1 2022. The put-call ratio across all filers is 0.17 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $23,184,000 | -37.8% | 2,409,961 | +8.8% | 4.90% | -41.1% |
Q1 2022 | $37,278,000 | -30.7% | 2,214,961 | -31.2% | 8.33% | -33.2% |
Q4 2021 | $53,791,000 | +20.4% | 3,217,163 | +17.0% | 12.46% | +5.8% |
Q3 2021 | $44,662,000 | +304.9% | 2,750,137 | +57.3% | 11.78% | +206.4% |
Q2 2021 | $11,031,000 | +3.2% | 1,748,241 | +1.1% | 3.84% | -9.7% |
Q1 2021 | $10,685,000 | +21.4% | 1,729,041 | +35.7% | 4.26% | -11.1% |
Q4 2020 | $8,805,000 | – | 1,274,261 | – | 4.79% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TCG Crossover Management, LLC | 2,516,920 | $42,360,000 | 17.00% |
COMMODORE CAPITAL LP | 2,214,961 | $37,278,000 | 8.33% |
Ally Bridge Group (NY) LLC | 650,000 | $10,940,000 | 8.11% |
Vivo Capital, LLC | 6,431,940 | $108,250,000 | 7.45% |
Samsara BioCapital, LLC | 1,262,551 | $21,249,000 | 5.35% |
Deep Track Capital, LP | 4,500,000 | $75,735,000 | 4.86% |
ACUTA CAPITAL PARTNERS, LLC | 539,500 | $9,080,000 | 4.24% |
Paradigm Biocapital Advisors LP | 910,416 | $15,322,000 | 4.05% |
Logos Global Management LP | 1,800,000 | $30,294,000 | 3.93% |
Yiheng Capital Management, L.P. | 5,058,585 | $85,136,000 | 3.89% |